Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2025-12-24 @ 11:53 AM
NCT ID:
NCT00893061
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed breast cancer
* No metastatic disease
* Meets criteria for initiating adjuvant endocrine therapy
* Hormone receptor status:
* Estrogen receptor- and/or progesterone receptor-positive disease
PATIENT CHARACTERISTICS:
* Postmenopausal, defined as no menstruation for ≥ 1 year, confirmed by a measurement of FSH and 17-beta-estradiol
* Karnofsky performance status 80-100%
* Native speaker of French
* Beneficiary of a French Social Security insurance plan
* No prior cognitive disorders
* No depression or other confirmed active psychiatric disease
* Able to undergo the medical monitoring of the trial due to geographic, social or psychological reasons
* No personal or family history of thromboembolic disease
PRIOR CONCURRENT THERAPY:
* No prior adjuvant chemotherapy
* No concurrent follow-up participation on another study
* No concurrent treatment with psychotropic substances (i.e., long half life benzodiazepines, antipsychotics, anticholinesterase)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00893061
Study Brief:
Protocol Section:
NCT00893061